Remove about health-policies grants
article thumbnail

May 11, 2023: Article outlines key stakeholder insights related to participant data sharing in pragmatic trials

Rethinking Clinical Trials

The article was published this month in Learning Health Systems. A key insight was that a “one size fits all” model for promoting broader sharing of data from pragmatic trials is not feasible, and policies must be sensitive to the unique challenges that pragmatic trials present, such as variation among trials. “Our

Trials 130
article thumbnail

New dawn for the EU’s joint procurement crisis response

Pharmaceutical Technology

The imminent rule changes will apply to crisis-relevant supplies of medical countermeasures, including both vaccines and therapeutics, where the threshold of a 'serious cross-border threat to health' is met. Some non-communicable diseases are, however, clearly covered and openly talked about for possible joint procurement prioritisation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Kite and Daiichi Sankyo update cell therapy licensing agreement

Pharmaceutical Technology

Regulators in Japan have granted approval for the manufacturing plant of Kite in El Segundo, California, US, to produce Yescarta for the Japanese market. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Thematic privacy policy.

Licensing 305
article thumbnail

New facility boosts UK’s cell and gene therapy manufacturing capacity

Pharmaceutical Technology

On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies.

article thumbnail

July 24, 2023: Bioethics Research Project Explores Data Sharing and Respect for Trial Participants

Rethinking Clinical Trials

The project was supported by a supplemental grant award from the NIH through the NIH HEAL Initiative. Morain and coauthors Juli Bolinger, Kevin Weinfurt, and Jeremy Sugarman published their work in an article in Clinical Trials and a report of stakeholder interviews in Learning Health Systems.

Trials 130
article thumbnail

China’s NMPA grants EUA to CSPC Pharmaceutical’s Covid-19 vaccine

Pharmaceutical Technology

China’s National Medical Products Administration (NMPA) has granted emergency use authorisation (EUA) for CSPC Pharmaceutical Group’s messenger RNA (mRNA) vaccine, SYS6006, to treat Covid-19. The latest authorisation from the Chinese health authority comes as cases of Covid-19 decline after a recent surge.

article thumbnail

NGOs claim UK-India free trade deal will raise medicine prices

pharmaphorum

Consumer and health organisations in the UK have written to the Trade Secretary Kemi Badenoch, saying a leaked chapter of the proposed UK-India free trade agreement (FTA) could raise the price of medicines used by the NHS. “India…supplies our NHS with 25% of all the medicines used to treat patients here in the UK,” they continue.